Trial Profile
A Double Blind Study Comparing Low Dose and High Dose IV Esomeprazole After Successful Endoscopic Therapy in Patients With Peptic Ulcer Bleeding.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Esomeprazole (Primary) ; Esomeprazole (Primary) ; Lansoprazole
- Indications Bleeding ulcer
- Focus Therapeutic Use
- 11 Aug 2011 Actual initiation date (Aug 2011) added as reported by ClinicalTrials.gov.
- 11 Aug 2011 Official Title amended as reported by ClinicalTrials.gov.
- 11 Aug 2011 Planned end date changed from 1 Jan 2013 to 1 Jan 2014 as reported by ClinicalTrials.gov.